Shotwise
Wegovy, Ozempic, Mounjaro
Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.
Worldwide Release Date: January 9, 2025
Star Ratings(129 ratings | avg ★ 4.6)
App Store (129 ratings)
Last 28 days
Revenue
$1,383
AR
$16,596
MRR
$1,512
ARR
$18,144
Cash Flow Index
0.9x
Active Subscriptions
1,014
Active Trials
1
ARPAS
$1.36
Paid Subscriber Share (snapshot)
99.9%
Active Customers
678
New Customers
147
Subscription Penetration
149.6%
ARPU
$2.04
RPD
$2.04
ARPPU
$1.49
LTV
$15
MRR Growth (28d)
-12.3%
Revenue Growth (28d)
-30.2%
Subscriber Growth (28d)
-9.5%
All data is verified through RevenueCat. Last updated: Apr 29, 2026, 03:30:52 PM UTC.
App Screenshots
In-App Pricing
Tech Stack
About This Listing
A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.
Asking Price
$30,240
Sale Details
Business Operations Started
Jan 2025
Assets Included in Sale
Source Code Included
Post-Sales Support
More apps for sale
Browse Marketplace ↗
Brainrot.mov
FOR SALELast 30 days rev
$25,977
MRR
$25,501
FitCal
FOR SALELast 30 days rev
$6,028
MRR
$7,788
-strive
FOR SALELast 30 days rev
$4,560
MRR
$9,924
Unlust
FOR SALELast 30 days rev
$2,704
MRR
$1,836
jurney
FOR SALELast 30 days rev
$1,691
MRR
$1,776
CalBuddy
Last 30 days rev
$76,201
MRR
$33,619



